NCT02180737View on ClinicalTrials.gov

Dexmedetomidine for Sedation During Radiological Interventional Procedures

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

January 31, 2015

Conditions
Procedural Sedation
Interventions
DRUG

Dexmeditomedine

Trial Locations (1)

112796

National Cancer Institute-Egypt, Cairo

All Listed Sponsors
lead

National Cancer Institute, Egypt

OTHER

NCT02180737 - Dexmedetomidine for Sedation During Radiological Interventional Procedures | Biotech Hunter | Biotech Hunter